2821 GENES FOUND
Show / hide columns
XML |
RDF |
TSV |
« prev | Page
of 57 | next »
IH abundance (Normal Tissue)
x
RNA abundance (Normal Tissue)
x
ADRM1 Adhesion regulating molecule 1
Nucleoplasm Plasma membrane Cytosol Renal cancer: 9.02e-6 Expressed in all
AEBP1 AE binding protein 1
Nucleoplasm Vesicles Cytosol Renal cancer: 9.31e-9 Glioma: 1.10e-4 Expressed in all
AFM Afamin
Liver cancer: 1.80e-4 Tissue enriched 6 liver: 467.3
AFP Alpha-fetoprotein
Cytosol Tissue enhanced liver: 1.9
AGA Aspartylglucosaminidase
Liver cancer: 1.99e-4 Head and neck cancer: 8.61e-4 Expressed in all
AGER Advanced glycosylation end product-specific receptor
Nucleoli fibrillar center Plasma membrane Cell Junctions Renal cancer: 9.01e-7 Urothelial cancer: 2.74e-6 Pancreatic cancer: 3.41e-4 Tissue enriched 181 lung: 891.2
AGK Acylglycerol kinase
Vesicles Mitochondria Expressed in all
AGMO Alkylglycerol monooxygenase
Vesicles Tissue enhanced liver: 63.6
AGPS Alkylglycerone phosphate synthase
Peroxisomes Liver cancer: 8.62e-6 Pancreatic cancer: 8.35e-4 Renal cancer: 9.45e-4 Expressed in all
AGR2 Anterior gradient 2, protein disulphide isomerase family member
Cytosol Renal cancer: 8.79e-5 Liver cancer: 1.15e-4 Tissue enhanced rectum: 1341.6 stomach: 1313.5
AGR3 Anterior gradient 3, protein disulphide isomerase family member
Endoplasmic reticulum Tissue enhanced fallopian tube: 349.7 small intestine: 264.9
AGRN Agrin
Plasma membrane Cytosol Liver cancer: 4.62e-4 Expressed in all
AGRP Agouti related neuropeptide N/A
Tissue enhanced adrenal gland: 5.8 epididymis: 24.7
AGT Angiotensinogen (serpin peptidase inhibitor, clade A, member 8)
Tissue enhanced cerebral cortex: 227.1 liver: 649.2
AGTPBP1 ATP/GTP binding protein 1
Nucleoli Vesicles Expressed in all
AGTRAP Angiotensin II receptor-associated protein
Vesicles Liver cancer: 6.57e-7 Expressed in all
AHCTF1 AT hook containing transcription factor 1
Nuclear membrane Renal cancer: 3.49e-8 Expressed in all
AHCYL2 Adenosylhomocysteinase-like 2
Nucleoplasm Cytosol Renal cancer: 1.08e-7 Head and neck cancer: 4.17e-4 Expressed in all
AHSG Alpha-2-HS-glycoprotein
Golgi apparatus Tissue enriched 1899 liver: 2819.2
AIG1 Androgen-induced 1
Golgi apparatus Head and neck cancer: 3.25e-7 Cervical cancer: 3.26e-6 Endometrial cancer: 3.06e-4 Expressed in all
AK4 Adenylate kinase 4
Mitochondria Pancreatic cancer: 4.34e-5 Cervical cancer: 4.17e-4 Renal cancer: 4.36e-4 Stomach cancer: 4.87e-4 Head and neck cancer: 8.83e-4 Tissue enhanced kidney: 189.1
AKAP10 A kinase (PRKA) anchor protein 10
Plasma membrane Cytosol Expressed in all
AKR1C1 Aldo-keto reductase family 1, member C1
Endoplasmic reticulum Cytosol Renal cancer: 8.03e-9 Liver cancer: 1.56e-4 Cervical cancer: 3.05e-4 Expressed in all
AL589743.1
Cytosol Tissue enhanced prostate: 9.5
ALAS2 5'-aminolevulinate synthase 2
Tissue enriched 7 bone marrow: 336.2
ALB Albumin
Endoplasmic reticulum Golgi apparatus Stomach cancer: 7.87e-4 Tissue enriched 221 liver: 105632.0
ALDH1B1 Aldehyde dehydrogenase 1 family, member B1
Nucleoplasm Vesicles Mitochondria Thyroid cancer: 1.17e-5 Renal cancer: 2.05e-4 Expressed in all
ALDH2 Aldehyde dehydrogenase 2 family (mitochondrial)
Liver cancer: 3.95e-7 Renal cancer: 5.24e-6 Endometrial cancer: 2.63e-4 Urothelial cancer: 7.71e-4 Expressed in all
ALDH9A1 Aldehyde dehydrogenase 9 family, member A1
Cytosol Pancreatic cancer: 4.56e-4 Expressed in all
ALDOA Aldolase A, fructose-bisphosphate
Cytosol Liver cancer: 5.79e-5 Lung cancer: 7.32e-5 Tissue enriched 7 skeletal muscle: 9379.1
ALG1 ALG1, chitobiosyldiphosphodolichol beta-mannosyltransferase
Nucleoli fibrillar center Endoplasmic reticulum Colorectal cancer: 5.79e-4 Testis cancer: 6.93e-4 Expressed in all
ALG5 ALG5, dolichyl-phosphate beta-glucosyltransferase
Cytosol Renal cancer: 1.40e-5 Head and neck cancer: 2.11e-4 Expressed in all
ALG9 ALG9, alpha-1,2-mannosyltransferase
Endoplasmic reticulum Renal cancer: 7.29e-5 Expressed in all
ALKBH1 AlkB homolog 1, histone H2A dioxygenase
Renal cancer: 1.80e-4 Mixed
ALKBH5 AlkB homolog 5, RNA demethylase
Nucleoplasm Golgi apparatus Cytosol Pancreatic cancer: 3.75e-4 Urothelial cancer: 5.69e-4 Expressed in all
ALKBH7 AlkB homolog 7
Renal cancer: 7.83e-6 Expressed in all
ALPI Alkaline phosphatase, intestinal
Plasma membrane Group enriched 31 duodenum: 208.8 small intestine: 216.4
ALPL Alkaline phosphatase, liver/bone/kidney
Cytosol Melanoma: 7.08e-4 Tissue enhanced lung: 78.9
ALPP Alkaline phosphatase, placental
Plasma membrane Pancreatic cancer: 4.33e-4 Group enriched 14 cervix, uterine: 25.2 placenta: 45.5
ALPPL2 Alkaline phosphatase, placental-like 2
Plasma membrane Tissue enhanced cervix, uterine: 1.1 fallopian tube: 1.9
AMBP Alpha-1-microglobulin/bikunin precursor
Endometrial cancer: 1.20e-4 Tissue enriched 22 liver: 5152.3
AMD1 Adenosylmethionine decarboxylase 1
Nucleoplasm Liver cancer: 1.91e-6 Breast cancer: 3.87e-4 Renal cancer: 4.28e-4 Expressed in all
AMICA1 Adhesion molecule, interacts with CXADR antigen 1
Head and neck cancer: 3.11e-4 Lung cancer: 3.92e-4 Tissue enhanced appendix: 84.3
AMPD1 Adenosine monophosphate deaminase 1
Tissue enriched 11 skeletal muscle: 208.6
AMT Aminomethyltransferase
Nucleoplasm Mitochondria Renal cancer: 3.90e-8 Expressed in all
AMTN Amelotin N/A
Tissue enhanced stomach: 7.0 tonsil: 25.8
AMY1A Amylase, alpha 1A (salivary)
Tissue enriched 80 salivary gland: 8907.0
AMY1B Amylase, alpha 1B (salivary)
Tissue enriched 15 salivary gland: 1847.5
AMY1C Amylase, alpha 1C (salivary)
Tissue enhanced cervix, uterine: 32.6 salivary gland: 102.5
AMY2A Amylase, alpha 2A (pancreatic)
Tissue enriched 313 pancreas: 31311.3
« prev | Page
of 57 | next »